Why the study?
Sudden cardiac deaths in young elite athletes have been remarkable, and screening for HCM is not mandatory. The study tested whether echocardiography-derived variables distinguish HCM from other variants of LV hypertrophy.
Does echocardiography accurately distinguish hypertrophic cardiomyopathy from physiological athlete's heart and hypertensive left ventricular hypertrophy?
Does echocardiography accurately distinguish hypertrophic cardiomyopathy from physiological athlete's heart and hypertensive left ventricular hypertrophy?
Echocardiographic parameters including global longitudinal strain, LV mass index, LA volume index, and septal TDI E/e' ratio can accurately distinguish hypertrophic cardiomyopathy from physiological athlete's heart and hypertensive LVH.
Answers are grounded in this paper and cite their sources.
These cutoffs may aid HCM differentiation from athlete's heart; leaves open prospective validation before routine use.
Over the past few years, the number of sudden cardiac deaths in young elite athletes has been remarkable. Unfortunately, screening for hypertrophic cardiomyopathy (HCM) is not mandatory in professional sports. Echocardiography remains the primary tool for assessing left ventricular (LV) structure and function. Therefore, we applied echocardiography to test whether echocardiography-derived variables accurately distinguish HCM from other variants of LV hypertrophy.
No takes yet. Share an insight, caveat, or question.
Foo et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: